Subscribe
Simon Thompson: As American investors become aware of the company鈥檚 potential, the dual-listed shares will re-rate
The private equity consortium that still holds 45 per cent of the company wants to take it private again
Simon Thompson: It posted a 16 per cent earnings beat, but only trades on a PE ratio of 12
Profitability may improve further from the second half of 2026
The immunotherapy specialist鈥檚 pipeline is about to enter a critical phase
The green hydrogen specialist should have enough cash to see it through to break-even
Simon Thompson: Analysts are upgrading earnings estimates, and a tender offer is being pitched at a healthy premium
Royalty company鈥檚 valuation has soared as investors rethink its new base metals portfolio
The recruiter is still handing out cash despite shrinking net fee income and a costly tech overhaul
Simon Thompson: It has delivered record lending, revenue and profit, but is still only priced on a forward PE ratio of 7.8
